article thumbnail

AI Use in Drug Discovery

Data Matters

Together, they discuss the challenges and opportunities AI presents for the pharmaceutical industry, particularly how AI is accelerating the pace of drug discovery and its implications for the future of medicine. The post AI Use in Drug Discovery appeared first on Data Matters Privacy Blog.

article thumbnail

Optimizing clinical trial site performance: A focus on three AI capabilities

IBM Big Data Hub

Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. Efficient clinical trial site selection continues to be a prominent industry-wide challenge.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CIPL Co-Hosts Workshop on GDPR and Scientific Health Research

Hunton Privacy

the “Workshop”) with the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) and the Future of Privacy Forum (“FPF”) to address the challenges raised by the EU General Data Protection Regulation (“GDPR”) in conducting scientific health research. Two extensive sessions followed these opening remarks.

GDPR 54
article thumbnail

Episode 158: How NotPetya has Insurers grappling with Systemic Cyber Risk

The Security Ledger

Related Stories Episode 155: Disinformation is a Cyber Weapon and APTs warm to Mobile Malware Podcast Episode 117: Insurance Industry Confronts Silent Cyber Risk, Converged Threats NotPetya Horror Story Highlights Need for Holistic Security. We talk to Bruce McDonnell of the East West Institute about how insurers are responding.

article thumbnail

MY TAKE: Why ‘basic research’ is so vital to bringing digital transformation to full fruition

The Last Watchdog

An estimated 60% of research and development in scientific and technical fields is carried out by private industry, with academic institutions and government accounting for 20% and 10%, respectively, according to the Organization for Economic Cooperation and Development. NTT Group, for instance, typically spends more than $3.6

article thumbnail

ABBYY Achieves Double-Digit Annual Revenue Growth for Third Consecutive Year

Info Source

ABBYY continued to see strong demand for its Digital Intelligence solutions in FY19, with customers including one of the world’s largest pharmaceutical companies, smart infrastructure solutions company Costain , a global medical supply manufacturer and distributor Medline , and other leading enterprises across industries.

article thumbnail

Delivering ROI for Our Customers When it Matters Most

Reltio

The study reported that a composite customer investing in Reltio's MDM solution achieved a 366% return on investment (ROI) and a total net present value of $13 million over three years, with a payback on their investment within six months once operational.

MDM 52